BriaCell's Phase 2 Trial Shows Promising Survival Rates in Metastatic Breast Cancer

BriaCell Therapeutics Corp. announced updated survival data from its Phase 2 clinical study of Bria-IMT in patients with metastatic breast cancer (MBC...
Home/KnloSights/Clinical Trial Updates/BriaCell's Phase 2 Trial Shows Promising Survival Rates in Metastatic Breast Cancer